Novavax, Inc. ( NVAX) - Stock Earnings
NVAX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
NVAX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 17.5 million USD | 147.1 million USD |
| 2026Q1 | -9.5 million USD | 139.5 million USD |
| 2026Q2 | -53.4 million USD | 56.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NVAX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -545.1 million USD | 556.4 million USD |
| 2024 | -187.5 million USD | 682.2 million USD |
| 2025 | 440.3 million USD | 1.1 billion USD |
| 2026 Est. | — | — |
NVAX
Price: $12.88
52 week price:
Earnings Per Share: -1.53 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 6.6 million
Ebitda: -37.6 millionMarket Capitalization: 1.7 billion